Parkinsons Treatment Market: By Drug Class, Dopamine Precursors, Catechol-o-methyltransferase Inhibitors, Peripheral Decarboxylase Inhibitors, Others ), By Distribution Channel and By Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Parkinsons Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Monoamine Oxidase Inhibitors (MAO), Dopamine Precursors, Catechol-o-methyltransferase Inhibitors (COMT), Peripheral Decarboxylase Inhibitors, Others (Anticholinergics, Antihistaminics)), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) and By Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Parkinsons Treatment Market size was valued at US$ 4,482.4 million in 2023, growing at a CAGR of 12.4% from 2024 to 2030. By drug class, the global market has been segmented into Monoamine Oxidase Inhibitors (MAO), Dopamine Precursors, Catechol-o-methyltransferase Inhibitors (COMT), Peripheral Decarboxylase Inhibitors, Others (Anticholinergics, Antihistaminics). The Peripheral Decarboxylase Inhibitors segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. It is attributed to the potency of the drug than other class of drugs. Based on distribution channel, the global market is segmented into Hospital Pharmacies, Online Pharmacies, Retail Pharmacies. Among these, the Hospital Pharmacies segment is expected to have the fastest-growing market during the forecast period 2023-2029

According to Precision Business Insights. It is due to the large patient base in the hospital which makes high demand in hospital pharmacies. Also, the growing number of patient visits to the hospital due to the availability of diagnostic laboratories and skilled professionals and doctors. parkinsons disease is the chronic, progressive neurodegenerative disorder that can be characterized by rigidity, tremors, postural instability and bradykinesia (slowness of movement). In Parkinson disorder, patients can also experience significant non-motor symptoms like changes in the sleep disturbances, autonomic erectile dysfunction and cognition and mood swings. The condition is attributed to the degeneration of the dopamine-producing cells of the substantia nigra.  

Parkinson's Treatment Market Key Developments

  • In Sept 2022, Kyowa Kirin announced the launch of new assets to help educate and empower adult patients to talk to their PD care team.
  • In Oct 2022, Muna Therapeutics announced that it has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).

summary download arrow Download Free Sample

Global Parkinsons Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.4%

Largest Market

North-America

Fastest Growing Market

North-America

Parkinsons Treatment Market Dynamics

Growing advancements in the treatment is anticipated to propel the market growth over the forecast years. Moreover, the increasing geriatric population, increasing prevalence of Parkinson disease around the globe, treatment affordability are boosting the global market growth over the forecast years.

Global Parkinsons Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 4,482.4 million

Market CAGR

12.4%

By Drug Class

  • Monoamine Oxidase Inhibitors (MAO)
  • Dopamine Precursors
  • Catechol-o-methyltransferase Inhibitors (COMT)
  • Peripheral Decarboxylase Inhibitors
  • Others (Anticholinergics, Antihistaminics)

By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The parkinsons treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The parkinsons treatment market size was valued at US$ 4,482.4 million in 2023, growing at a CAGR of 12.4% from 2024 to 2030

New products and therapy launch especially research on gene therapy are trending in the global market which will further drive the market growth in the forecasted years.

The shift towards research activities from symptomatic treatment to Parkinson disorder modifying treatment will create lucrative growth in the global market.

Present of alternatives are the major restraining factors in the global market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Parkinsons Treatment Market Introduction 
2.1.Global Parkinsons Treatment Market  - Taxonomy
2.2.Global Parkinsons Treatment Market  - Definitions
2.2.1.Drug Class
2.2.2.Distribution Channel
2.2.3.Region
3. Global Parkinsons Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Parkinsons Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Parkinsons Treatment Market  By Drug Class, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Monoamine Oxidase Inhibitors (MAO)
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Dopamine Precursors
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Catechol-o-methyltransferase Inhibitors (COMT)
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Peripheral Decarboxylase Inhibitors
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others (Anticholinergics, Antihistaminics)
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Parkinsons Treatment Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Online Pharmacies
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Retail Pharmacies
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Parkinsons Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Parkinsons Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Monoamine Oxidase Inhibitors (MAO)
8.1.2.Dopamine Precursors
8.1.3.Catechol-o-methyltransferase Inhibitors (COMT)
8.1.4.Peripheral Decarboxylase Inhibitors
8.1.5.Others (Anticholinergics, Antihistaminics)
8.2.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospital Pharmacies
8.2.2.Online Pharmacies
8.2.3.Retail Pharmacies
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Parkinsons Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Monoamine Oxidase Inhibitors (MAO)
9.1.2.Dopamine Precursors
9.1.3.Catechol-o-methyltransferase Inhibitors (COMT)
9.1.4.Peripheral Decarboxylase Inhibitors
9.1.5.Others (Anticholinergics, Antihistaminics)
9.2.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospital Pharmacies
9.2.2.Online Pharmacies
9.2.3.Retail Pharmacies
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10. Asia Pacific (APAC) Parkinsons Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Monoamine Oxidase Inhibitors (MAO)
10.1.2.Dopamine Precursors
10.1.3.Catechol-o-methyltransferase Inhibitors (COMT)
10.1.4.Peripheral Decarboxylase Inhibitors
10.1.5.Others (Anticholinergics, Antihistaminics)
10.2.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospital Pharmacies
10.2.2.Online Pharmacies
10.2.3.Retail Pharmacies
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Parkinsons Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Monoamine Oxidase Inhibitors (MAO)
11.1.2.Dopamine Precursors
11.1.3.Catechol-o-methyltransferase Inhibitors (COMT)
11.1.4.Peripheral Decarboxylase Inhibitors
11.1.5.Others (Anticholinergics, Antihistaminics)
11.2.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospital Pharmacies
11.2.2.Online Pharmacies
11.2.3.Retail Pharmacies
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Parkinsons Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Monoamine Oxidase Inhibitors (MAO)
12.1.2.Dopamine Precursors
12.1.3.Catechol-o-methyltransferase Inhibitors (COMT)
12.1.4.Peripheral Decarboxylase Inhibitors
12.1.5.Others (Anticholinergics, Antihistaminics)
12.2.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospital Pharmacies
12.2.2.Online Pharmacies
12.2.3.Retail Pharmacies
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Salix Pharmaceuticals (U.S.)
13.2.2.GlaxoSmithKline Plc. (U.K.)
13.2.3.Wockhardt Limited (India)
13.2.4.Impax Laboratories, Inc. (U.S)
13.2.5.Novartis AG (Switzerland)
13.2.6.Mylan N.V (U.S)
13.2.7.Teva Pharmaceutical Industries Ltd.(Israel)
13.2.8.Cipla Inc.(India)
13.2.9.Par Pharmaceutical (U.S)
13.2.10.Apotex Inc (Canada)
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Salix Pharmaceuticals (U.S.)
  • GlaxoSmithKline Plc. (U.K.)
  • Wockhardt Limited (India)
  • Impax Laboratories, Inc. (U.S)
  • Novartis AG (Switzerland)
  • Mylan N.V (U.S)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Cipla Inc.(India)
  • Par Pharmaceutical (U.S)
  • Apotex Inc (Canada)

Related Industry Reports

Global Radiotherapy Market

Global Cancer Gene Therapy Market

Global Stem Cell Therapy Market

Global Anaphylaxis Treatment Market